World leading research receives cash boost in Manchester
Cancer Research UK will invest an additional £6m each year into world-leading research in Manchester and create up to an additional 100 new jobs. The charity’s annual investment into the Cancer Research […]
MHRA grants approval of Sanofi’s Sarclisa (isatuximab) subcutaneous (SC) as the UK’s first anticancer treatment administered via an on-body injector (OBI)
Sanofi is pleased to announce that the United Kingdom (UK) Medicines and Healthcare products Regulatory agency (MHRA) has granted marketing authorisation for Sarclisa (isatuximab) for subcutaneous (SC) use in combination […]
GenesisCare selected by University Hospitals Dorset to provide private cancer services across the region
Following a highly competitive tendering process, GenesisCare, the UK’s leading independent cancer care provider, has been selected by University Hospitals Dorset (UHD) as its preferred partner to provide much needed […]
Charity launches patient guide for rare type of non-smoking lung cancer
ALK Positive UK has today launched its new guide to help people diagnosed with ALK-positive lung cancer to ask the right questions of their healthcare professionals during medical consultations.1 ALK-positive […]
GenesisCare and UKONS host first ever joint National Nurse Symposium
GenesisCare – in partnership with the United Kingdom Oncology Nursing Society (UKONS) – has hosted the first-ever joint National Nurse Symposium at the Royal College of Nursing in London. Over […]
Barts Health patients set to benefit from new life-extending drug for ovarian cancer
A new drug that extends survival for women with hard-to-treat ovarian cancer is now available on the NHS. The treatment was tested at St Bartholomew’s Hospital as part of a […]
NICE recommends pirtobrutinib (Jaypirca ▼) as an option to treat relapsed or refractory chronic lymphocytic leukaemia (CLL) in adults who have previously been treated with a Bruton’s tyrosine kinase (BTK) inhibitor[i]
Today, Eli Lilly and Company (Lilly) announced that the National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending pirtobrutinib for use on the NHS in […]
Antibody may improve treatment response in lung cancer
An experimental antibody treatment that binds to a protein known as PCDH7 shrank tumours in preclinical models of non-small cell lung cancer (NSCLC), even those resistant to a targeted therapy, […]
Hundreds of cancer patients to benefit from improved access to genetic testing
Cancer Research UK has announced that from now it is making hundreds of specialised blood tests available to people affected by cancer across the UK. As a co-funder of the […]
Cancer hospital experts develop new dose monitoring system for UK’s national eye proton therapy service
A team from The Clatterbridge Cancer Centre have used their ingenuity and expertise to develop a new dose monitoring system for the UK’s national eye proton therapy service, with funding […]
